Associate Professor, Medicine, University of Maryland School of Medicine
Oncology
Dr. Petr F. Hausner, MD
|
|
Give Review
Petr Hausner works in the field of Oncology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Petr F. Hausner, MD is also a published MD. He has 19 paper published. The most recent paper is: Changes in skeleton, bone marrow reactivity and in immunity of patients with tumors of testis during long-term complete clinical remission. Petr Hausner accepts Medicare.
Publications
- Image-guided Thermal Ablation of Tumor Increases the Plasma Level of Interleukin-6 and Interleukin-10: Is Plasma Level of Interleukin-6 a Surrogate for Immunogenic Cel...
- 18F-FDG PET/CT in a Recurrent Diffuse Malignant Peritoneal Mesothelioma.
- CASE 1. Testis: a sanctuary site in Merkel cell Carcinoma.
- [Comprehensive diagnostic approaches to tumor metastases in the skeleton. V. The relation of biochemical indicators to age in the diagnosis of bone metastases of stage...
- [Comprehensive diagnostic approaches to tumor metastases in the skeleton. IV. Cytomorphologic and biochemical diagnosis of bone metastases of stage II Carcinoma of the...
- [Comprehensive diagnostic approaches to tumor metastases in the skeleton. III. Scintigraphy of the skeleton in the diagnosis of stage II metastatic Carcinoma of the br...
- Changes in skeleton, bone marrow reactivity and in immunity of patients with Tumors of testis during long-term complete clinical remission.
- The "comparative growth assay": examining the interplay of anti-Cancer agents with cells carrying single gene alterations.
- The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus Tumors.
- Accurate lymph node assessment prior to trimodality therapy for esophageal Carcinoma.
- Phase I study of docetaxel and topotecan in patients with solid Tumors.
- Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ ...
- Pneumonectomy for lung Cancer after preoperative concurrent chemotherapy and high-dose radiation.
- Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung Cancer.
- High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and exCellent long-term survival.
- Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung Cancer.
- Outcomes after trimodality therapy for esophageal Cancer: the impact of histology on failure patterns.
- Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung Cancer.
Schools
Charles University Faculty of Medicine in Prague
Charles University Faculty Med
National Cancer Institute
NciNih Lab Gene
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Select
- Amerigroup (Wellpoint)
- Amerihealth
- Assurant Health
- Blue Card PPO
- Blue Choice Advantage
- Blue Choice Network POS
- Blue Preferred PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- GEHA
- HealthPartners
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Maryland Physicians Care
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Karlovy University Faculty of Medicine
Hospital
-
University of Maryland Baltimore Washington Medical Center -
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1376534222 | |
| NPPES Provider LastName | HAUSNER | |
| NPPES Provider FirstName | PETR | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 147.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 8.84 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1376534222 |
| Last Name Of The Provider | HAUSNER |
| First Name Of The Provider | PETR |
| View All |
Similar Doctors
|
|
Dr. Arif Hussain, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. Cullen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christine H. Chung, MD |
|
|
Dr. David A. Riseberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dung T. Le, MD |
|
|
Dr. Mary Y. Armanios, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Joshua F. Zeidner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manuel H. Medina, MD |